These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35378020)

  • 21. Detour of bile acid routes as therapeutic roadmap for cholemic nephropathy.
    Fickert P
    J Hepatol; 2024 Feb; 80(2):188-190. PubMed ID: 38013144
    [No Abstract]   [Full Text] [Related]  

  • 22. Bile cast nephropathy causing acute kidney injury in a patient with nonfulminant acute hepatitis A.
    Ravi R; Suthar K; Murlidharan P; Lakshmi K; Balan S; Safeer M
    Saudi J Kidney Dis Transpl; 2018; 29(6):1498-1501. PubMed ID: 30588986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cholemic tubulonephrosis].
    Emanuelli G; Camussi G; Gatti G; Anfossi G; Robecchi A; Calcamuggi G; Cestonaro G
    Recenti Prog Med; 1978 Jun; 64(6):671-700. PubMed ID: 370932
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatocyte growth factor reverses cholemic nephropathy associated with α-naphthylisothiocyanate-induced cholestasis in mice.
    Salas-Silva S; López-Ramirez J; Barrera-Chimal J; Lazzarini-Lechuga R; Simoni-Nieves A; Souza V; Miranda-Labra RU; Masso F; Roma MG; Gutiérrez-Ruiz MC; Bucio-Ortiz L; Gomez-Quiroz LE
    Life Sci; 2022 Apr; 295():120423. PubMed ID: 35196530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bile salt nephropathy/cholemic nephrosis].
    Leclerc M; Lanot A; Béchade C; Le Naoures C; Comoz F; Lobbedez T
    Nephrol Ther; 2016 Nov; 12(6):460-462. PubMed ID: 27262935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal failure in obstructive jaundice--pathogenic factors.
    Wardle EN
    Postgrad Med J; 1975 Aug; 51(598):512-4. PubMed ID: 1234333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cholemic hemorrhages].
    Kal'chenko II; Lys PV
    Klin Khir (1962); 1970 Dec; 12():61-9. PubMed ID: 4996489
    [No Abstract]   [Full Text] [Related]  

  • 28. Dithiothreitol supplementation mitigates hepatic and renal injury in bile duct ligated mice: Potential application in the treatment of cholestasis-associated complications.
    Heidari R; Ghanbarinejad V; Mohammadi H; Ahmadi A; Esfandiari A; Azarpira N; Niknahad H
    Biomed Pharmacother; 2018 Mar; 99():1022-1032. PubMed ID: 29307496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural history, spectrum and outcome of stage 3 AKI in patients with acute-on-chronic liver failure.
    Maiwall R; Rastogi A; Pasupuleti SSR; Hidam AK; Singh M; Kadyan S; Jain P; Kumar G; Sarin SK
    Liver Int; 2022 Dec; 42(12):2800-2814. PubMed ID: 36017749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholemic or Bile Cast Nephropathy in a Child with Liver Failure.
    Sood V; Lal BB; Lata S; Rastogi A; Alam S
    J Clin Exp Hepatol; 2017 Dec; 7(4):373-375. PubMed ID: 29234203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cholestasis-induced liver injury: the role of S1PR2].
    Dissous L; Cesard E; Dance A; Tordjmann T
    Med Sci (Paris); 2017; 33(6-7):606-609. PubMed ID: 28990561
    [No Abstract]   [Full Text] [Related]  

  • 32. Further study into obstructive jaundice and ischaemic renal damage.
    Baum M; Stirling GA; Dawson JL
    Br Med J; 1969 Apr; 2(5651):229-31. PubMed ID: 5780433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formation of biliary thrombi in protoporphyrin-induced cholestasis in perfused rat liver.
    Berenson MM; Gunther C; Samowitz WS; Bjorkman DJ
    Hepatology; 1990 May; 11(5):757-63. PubMed ID: 2347550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bile-acid metabolism and the liver.
    Williams CN
    Clin Biochem; 1976 Jun; 9(3):149-52. PubMed ID: 1277449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do Biliary Salts Have Role on Acute Kidney Injury Development?
    Romano TG; Vieira Junior JM
    J Clin Med Res; 2015 Sep; 7(9):667-71. PubMed ID: 26251679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic targets for cholestatic liver injury.
    Woolbright BL; Jaeschke H
    Expert Opin Ther Targets; 2016; 20(4):463-75. PubMed ID: 26479335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acute kidney injury in liver failure].
    Werner CR; Wagner V; Sipos B; Büttner-Herold M; Amann K; Haap M; Malek NP; Bitzer M; Artunc F
    Dtsch Med Wochenschr; 2016 Oct; 141(21):1559. PubMed ID: 27750343
    [No Abstract]   [Full Text] [Related]  

  • 38. Hormesis in Cholestatic Liver Disease; Preconditioning with Low Bile Acid Concentrations Protects against Bile Acid-Induced Toxicity.
    Verhaag EM; Buist-Homan M; Koehorst M; Groen AK; Moshage H; Faber KN
    PLoS One; 2016; 11(3):e0149782. PubMed ID: 26950211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial dysfunction as a mechanism involved in the pathogenesis of cirrhosis-associated cholemic nephropathy.
    Heidari R; Mandegani L; Ghanbarinejad V; Siavashpour A; Ommati MM; Azarpira N; Najibi A; Niknahad H
    Biomed Pharmacother; 2019 Jan; 109():271-280. PubMed ID: 30396085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathophysiology of cholestasis.
    Popper H; Schaffner F
    Hum Pathol; 1970 Mar; 1(1):1-24. PubMed ID: 4940286
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.